PepGen Inc. (PEPG)
3.15
-0.06
(-1.87%)
USD |
NASDAQ |
Sep 09, 15:46
PepGen Total Assets (Quarterly) : 141.40M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 141.40M |
| March 31, 2026 | 156.30M |
| December 31, 2025 | 173.91M |
| September 30, 2025 | 190.06M |
| June 30, 2025 | 102.24M |
| March 31, 2025 | 127.39M |
| December 31, 2024 | 150.88M |
| September 30, 2024 | 170.23M |
| June 30, 2024 | 193.51M |
| March 31, 2024 | 207.00M |
| December 31, 2023 | 143.05M |
| September 30, 2023 | 164.27M |
| Date | Value |
|---|---|
| June 30, 2023 | 182.08M |
| March 31, 2023 | 201.04M |
| December 31, 2022 | 217.44M |
| September 30, 2022 | 208.46M |
| June 30, 2022 | 230.80M |
| March 31, 2022 | 131.88M |
| December 31, 2021 | 143.64M |
| September 30, 2021 | 149.05M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 10.64M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.86M |
| Shareholders Equity (Quarterly) | 119.53M |
| Debt to Equity Ratio | 0.1346 |
| Current Ratio | 13.36 |
| Net Debt Paydown Yield | 0.35% |